Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia- parkinsonism

Allison Brashear, Ian J. Butler, Keith Hyland, Martin R. Farlow, William B. Dobyns

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Rapid-onset dystonia-parkinsonism (RDP) is characterized by sudden onset over hours to days of dystonia, dysphagia, dysarthria, and parkinsonism. RDP has been reported by our group in two apparently unrelated families. We now report analysis of cerebrospinal fluid metabolites of dopamine, norepinephrine, and serotonin for mild and severely affected individuals, known asymptomatic gene carriers, and at-risk individuals from both families with RDP. Levels of the dopamine metabolite homovanillic acid (HVA) were decreased in severely affected patients and in some asymptomatic gene carriers. HVA levels increased with treatment in some affected individuals, but this increase did not predict clinical response to carbidopa/levodopa. We suggest that a low HVA level is a biological marker with modest association to the diagnosis of RDP.

Original languageEnglish (US)
Pages (from-to)521-526
Number of pages6
JournalAnnals of Neurology
Volume43
Issue number4
DOIs
StatePublished - Apr 1 1998

Fingerprint

Homovanillic Acid
Cerebrospinal Fluid
Dopamine
Dysarthria
Dystonia
Parkinsonian Disorders
Deglutition Disorders
Genes
Serotonin
Norepinephrine
Biomarkers
Dystonia 12
Therapeutics

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia- parkinsonism. / Brashear, Allison; Butler, Ian J.; Hyland, Keith; Farlow, Martin R.; Dobyns, William B.

In: Annals of Neurology, Vol. 43, No. 4, 01.04.1998, p. 521-526.

Research output: Contribution to journalArticle

Brashear, Allison ; Butler, Ian J. ; Hyland, Keith ; Farlow, Martin R. ; Dobyns, William B. / Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia- parkinsonism. In: Annals of Neurology. 1998 ; Vol. 43, No. 4. pp. 521-526.
@article{15be6ecc80014f88ab9951b480f82a62,
title = "Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia- parkinsonism",
abstract = "Rapid-onset dystonia-parkinsonism (RDP) is characterized by sudden onset over hours to days of dystonia, dysphagia, dysarthria, and parkinsonism. RDP has been reported by our group in two apparently unrelated families. We now report analysis of cerebrospinal fluid metabolites of dopamine, norepinephrine, and serotonin for mild and severely affected individuals, known asymptomatic gene carriers, and at-risk individuals from both families with RDP. Levels of the dopamine metabolite homovanillic acid (HVA) were decreased in severely affected patients and in some asymptomatic gene carriers. HVA levels increased with treatment in some affected individuals, but this increase did not predict clinical response to carbidopa/levodopa. We suggest that a low HVA level is a biological marker with modest association to the diagnosis of RDP.",
author = "Allison Brashear and Butler, {Ian J.} and Keith Hyland and Farlow, {Martin R.} and Dobyns, {William B.}",
year = "1998",
month = "4",
day = "1",
doi = "10.1002/ana.410430417",
language = "English (US)",
volume = "43",
pages = "521--526",
journal = "Annals of Neurology",
issn = "0364-5134",
publisher = "John Wiley and Sons Inc.",
number = "4",

}

TY - JOUR

T1 - Cerebrospinal fluid homovanillic acid levels in rapid-onset dystonia- parkinsonism

AU - Brashear, Allison

AU - Butler, Ian J.

AU - Hyland, Keith

AU - Farlow, Martin R.

AU - Dobyns, William B.

PY - 1998/4/1

Y1 - 1998/4/1

N2 - Rapid-onset dystonia-parkinsonism (RDP) is characterized by sudden onset over hours to days of dystonia, dysphagia, dysarthria, and parkinsonism. RDP has been reported by our group in two apparently unrelated families. We now report analysis of cerebrospinal fluid metabolites of dopamine, norepinephrine, and serotonin for mild and severely affected individuals, known asymptomatic gene carriers, and at-risk individuals from both families with RDP. Levels of the dopamine metabolite homovanillic acid (HVA) were decreased in severely affected patients and in some asymptomatic gene carriers. HVA levels increased with treatment in some affected individuals, but this increase did not predict clinical response to carbidopa/levodopa. We suggest that a low HVA level is a biological marker with modest association to the diagnosis of RDP.

AB - Rapid-onset dystonia-parkinsonism (RDP) is characterized by sudden onset over hours to days of dystonia, dysphagia, dysarthria, and parkinsonism. RDP has been reported by our group in two apparently unrelated families. We now report analysis of cerebrospinal fluid metabolites of dopamine, norepinephrine, and serotonin for mild and severely affected individuals, known asymptomatic gene carriers, and at-risk individuals from both families with RDP. Levels of the dopamine metabolite homovanillic acid (HVA) were decreased in severely affected patients and in some asymptomatic gene carriers. HVA levels increased with treatment in some affected individuals, but this increase did not predict clinical response to carbidopa/levodopa. We suggest that a low HVA level is a biological marker with modest association to the diagnosis of RDP.

UR - http://www.scopus.com/inward/record.url?scp=0031780914&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031780914&partnerID=8YFLogxK

U2 - 10.1002/ana.410430417

DO - 10.1002/ana.410430417

M3 - Article

C2 - 9546335

AN - SCOPUS:0031780914

VL - 43

SP - 521

EP - 526

JO - Annals of Neurology

JF - Annals of Neurology

SN - 0364-5134

IS - 4

ER -